We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App





QuidelOrtho Demonstrates Advanced Diagnostic Laboratory Solutions across Healthcare Continuum

By LabMedica International staff writers
Posted on 29 Jul 2024

At the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 conference, QuidelOrtho Corporation (San Diego, CA, USA) is presenting its flexible and reliable solutions that deliver quality diagnostic results across the entire healthcare continuum - from home to hospital, lab to clinic. More...

QuidelOrtho is providing onsite demonstrations of its diverse product lines including Vitros automation solutions which can reduce manual steps, increase efficiency, and free up lab staff to focus on the delivery of quality results while reducing operational costs. QuidelOrtho is also demonstrating the Vitros XT 7600 system which offers a full clinical chemistry and immunoassay menu in one easy-to-use system that delivers industry-leading uptime. The system’s built-in technologies improve efficiency and quality, allowing for scalable automation solutions that streamline workflow. Visitors to QuidelOrtho’s booth at ADLM 2024 can experience the Vitros XT 3400 Chemistry System which is powered by intelligent technologies and digital imaging technology to help labs meet routine testing needs, with proven high-quality results and system reliability in a small footprint. QuidelOrtho is also demonstrating the Ortho Vision Max Swift analyzer which is built on the proven design of the Ortho Vision platform and maximizes efficiency with dependable full menu automation.

Additionally, attendees can also join an insightful session sponsored by QuidelOrtho on "How labs evolve when Sigma metrics are provided automatically." In addition to exploring how having assay Sigma metrics at the fingertips can transform lab management, attendees can learn what industry experts did with their data, the improvements they made, and how it impacted their operations. QuidelOrtho is also sponsoring the Society of Young Clinical Laboratorians (SYCL) events at ADLM 2024, demonstrating its commitment to supporting the next generation of clinical laboratorians and their professional development.


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Steam Sterilizer
Hi Vac II Line
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.